Creatine Safety and Tolerability in Premanifest HD: PRECREST

NCT00592995 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Huntington Disease

Interventions

DRUG: Creatine monohydrate
DRUG: Placebo

Sponsor

Massachusetts General Hospital